A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor developmentJennifer M. Burns, Thomas J. Schall, Bretton C. Summers et al.|The Journal of Experimental Medicine|2006Cited by 1.3k
First-in-Human, First-in-Class Phase I Trial of the Anti-CD47 Antibody Hu5F9-G4 in Patients With Advanced CancersBranimir I. Šikić, Sukhmani K. Padda, A. Dimitrios Colevas et al.|Journal of Clinical Oncology|2019Cited by 590
CXCR7 (RDC1) promotes breast and lung tumor growth <i>in vivo</i> and is expressed on tumor-associated vasculatureZhenhua Miao, Thomas J. Schall, Kathryn E. Luker et al.|Proceedings of the National Academy of Sciences|2007Cited by 532